Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestiv (Q34665199)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestiv |
scientific article |
Statements
1 reference
Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestiv (English)
1 reference
Rosine Guimbaud
1 reference
Christophe Louvet
1 reference
Pauline Ries
1 reference
Emilie Maillard
1 reference
Jean-Marc Gornet
1 reference
Thomas Aparicio
1 reference
Suzanne Nguyen
1 reference
Ahmed Azzedine
1 reference
Pierre-Luc Etienne
1 reference
Eveline Boucher
1 reference
Christine Rebischung
1 reference
Philippe Rougier
1 reference
Laurent Bedenne
1 reference
Olivier Bouché
1 reference
6 October 2014
1 reference
1 reference
Identifiers
1 reference